Literature DB >> 2358776

Analysis of somatic mutations in kappa transgenes.

J Hackett1, B J Rogerson, R L O'Brien, U Storb.   

Abstract

We have examined the nature and localization of somatic mutations in three kappa transgenes cloned from IgG-secreting hybridomas. All of the mutations identified were single base substitutions. Mutations were localized to the variable (V) region and its flanking sequences. In every case, the nuclear matrix association region, kappa enhancer, and C gene were spared. These data indicate that the rearranged kappa gene contains the necessary sequences for targeting of the mutation process, and suggest that the observed localization of mutations to the V region reflects the inherent specificity of this mutation process.

Mesh:

Substances:

Year:  1990        PMID: 2358776      PMCID: PMC2188163          DOI: 10.1084/jem.172.1.131

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  A hyperconversion mechanism generates the chicken light chain preimmune repertoire.

Authors:  C A Reynaud; V Anquez; H Grimal; J C Weill
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

2.  Somatic diversification of the chicken immunoglobulin light chain gene is limited to the rearranged variable gene segment.

Authors:  C B Thompson; P E Neiman
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

3.  Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites.

Authors:  P N Cockerill; W T Garrard
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

4.  Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region.

Authors:  C A Reynaud; A Dahan; V Anquez; J C Weill
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

Review 5.  Gene conversion and the generation of antibody diversity.

Authors:  L J Wysocki; M L Gefter
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

6.  Patterns of somatic mutations in immunoglobulin variable genes.

Authors:  G B Golding; P J Gearhart; B W Glickman
Journal:  Genetics       Date:  1987-01       Impact factor: 4.562

7.  Clusters of point mutations are found exclusively around rearranged antibody variable genes.

Authors:  P J Gearhart; D F Bogenhagen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.

Authors:  J Durdik; R M Gerstein; S Rath; P F Robbins; A Nisonoff; E Selsing
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Sequence analysis of non-expressed immunoglobulin heavy chain loci in clonally related, somatically mutated hybridoma cells.

Authors:  F Sablitzky; D Weisbaum; K Rajewsky
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

10.  Transgenic mice with mu and kappa genes encoding antiphosphorylcholine antibodies.

Authors:  U Storb; C Pinkert; B Arp; P Engler; K Gollahon; J Manz; W Brady; R L Brinster
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  15 in total

1.  Error-prone DNA repair activity during somatic hypermutation in shark B lymphocytes.

Authors:  Catherine Zhu; Ellen Hsu
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  Boundaries of somatic mutation in rearranged immunoglobulin genes: 5' boundary is near the promoter, and 3' boundary is approximately 1 kb from V(D)J gene.

Authors:  S G Lebecque; P J Gearhart
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

3.  Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

Authors:  Lucia Kato; Nasim A Begum; A Maxwell Burroughs; Tomomitsu Doi; Jun Kawai; Carsten O Daub; Takahisa Kawaguchi; Fumihiko Matsuda; Yoshihide Hayashizaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  JH6 downstream intronic sequence is dispensable for RNA polymerase II accumulation and somatic hypermutation of the variable gene in Ramos cells.

Authors:  Diana P Castiblanco; Darrell D Norton; Robert W Maul; Patricia J Gearhart
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

5.  A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.

Authors:  Ai Kotani; Il-Mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Nasim A Begum; Toshiharu Nakajima; Hirohisa Saito; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes.

Authors:  A Umar; P A Schweitzer; N S Levy; J D Gearhart; P J Gearhart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 7.  AID and Apobec3G haphazard deamination and mutational diversity.

Authors:  Malgorzata Jaszczur; Jeffrey G Bertram; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

8.  Mutation pattern of immunoglobulin transgenes is compatible with a model of somatic hypermutation in which targeting of the mutator is linked to the direction of DNA replication.

Authors:  B Rogerson; J Hackett; A Peters; D Haasch; U Storb
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes.

Authors:  M J Sharpe; C Milstein; J M Jarvis; M S Neuberger
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

10.  A hypermutable insert in an immunoglobulin transgene contains hotspots of somatic mutation and sequences predicting highly stable structures in the RNA transcript.

Authors:  U Storb; E L Klotz; J Hackett; K Kage; G Bozek; T E Martin
Journal:  J Exp Med       Date:  1998-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.